Nova Southeastern University

Running trials

• Enrolling by invitation

  The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab

  NCT07688239· Phase 2· Tiziana Life Sciences LTD· Source

• Recruiting

  Healey ALS MyMatch Common Screening Protocol

  NCT07400393· Massachusetts General Hospital· Source

• Recruiting

  Tongue-strengthening Exercises in People With ALS.

  NCT07295990· Nova Southeastern University· Source

• Active, not recruiting

  Study of COYA 302 for the Treatment of ALS

  NCT07161999· Phase 2/3· Coya Therapeutics· Source

• Recruiting

  SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)

  NCT07021794· Phase 2· Nancy Klimas· Source

• Not yet recruiting

  Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)

  NCT06973629· Phase 3· Brainstorm-Cell Therapeutics· Source

• Recruiting

  (CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000

  NCT07680244· Carl Zeiss Meditec-Dublin CoCe· Source

• Recruiting

  Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners

  NCT06581523· Nova Southeastern University· Source

• Recruiting

  ASSESS ALL ALS Study

  NCT06578195· St. Joseph's Hospital and Medical Center, Phoenix· Source

• Recruiting

  Investigating Cardiac Health of Adults With Trauma

  NCT05700201· Nova Southeastern University· Source

• Active, not recruiting

  Assessing the Gut Microbiome and Its Association With Pediatric Stress and Cognition

  NCT06269614· Nova Southeastern University· Source

• Active, not recruiting

  HEALEY ALS Platform Trial - Master Protocol

  NCT04297683· Phase 2/3· Merit E. Cudkowicz, MD· Source

• Active, not recruiting

  Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa

  NCT02086890· Nova Southeastern University· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• ALS (motor neurone disease)5 recruiting
• Long COVID and ME/CFS1 recruiting
• Macular degeneration1 recruiting
• Parkinson disease1 recruiting
• Post-traumatic stress disorder (PTSD)1 recruiting

Closed trials

• Completed

  Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)

  NCT07047209· Phase 2· Massachusetts General Hospital· Source

• Completed

  The Effects of a Psychoeducational Intervention on Health and Performance-based Outcomes of Veterans Diagnosed With PTSD

  NCT06403514· Nova Southeastern University· Source

• Completed

  Assessing Impacts of Static Magnetic Fields on Peripheral Pulses and Skin Blood Flow

  NCT04539704· Nova Southeastern University· Source

• Completed

  Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)

  NCT05152953· University of California, San Francisco· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Long COVID and ME/CFS12 works · 1 trial
• Hypothyroidism8 works · 0 trials
• Dermatomyositis and polymyositis (myositis)5 works · 0 trials
• Hyperparathyroidism4 works · 0 trials
• Trigeminal neuralgia3 works · 0 trials